COVID-19 AND OSTEOPOROSIS TREATMENTS FOR PATIENTS AND CAREGIVERS
As we work to adjust to our new normal during COVID-19, now more than ever, staying fracture-free is critical for anyone with osteoporosis.
BONE MATTERS: DRUG-INDUCED OSTEOPOROSIS
In this video presentation Dr. Yuksel answers questions such as:
- The effects of drug-induced osteoporosis on bone loss and fracture risk
- How drug-induced osteoporosis is assessed
- The management of drugs that lead to bone loss and fractures
- Certain drugs that contribute to bone loss and increased fracture risk, including glucocorticoids, aromatase inhibitors for breast cancer and androgen deprivation therapy for prostate cancer